Abbott Agrees to $670 Million Settlement in Preterm Infant Formula Litigation
Abbott has agreed to pay $670 million to partially settle thousands of claims alleging that its specialty infant formulas for…
Abbott has agreed to pay $670 million to partially settle thousands of claims alleging that its specialty infant formulas for…
Continuing its long-standing tradition of organising biannual pacemaker check-up camps on the last Sunday of June and December, Gangasheel Hospital…
Abbott India Limited has been served with a GST penalty order amounting to ₹2.40 crore by the Office of the…
Abbott, the global healthcare leader, has unveiled a new and improved version of its nutritional product ‘Ensure Diabetes Care’ in…
Indian medical device manufacturers fear that the proposed GST reforms could make imports cheaper and erode domestic competitiveness. Association of…